Skip to main content
. 2017 Oct 25;24(5):e341–e347. doi: 10.3747/co.24.3579

TABLE II.

Observed brain cancer survival probabilities by diagnostic method and histology

Category Pts (n) Survival probability (95% CL) by years since diagnosis

1 Year 2 Years 3 Years 4 Years 5 Years 6 Years
Overall 20,875 0.47 (0.46, 0.48) 0.34 (0.33, 0.35) 0.30 (0.29, 0.30) 0.27 (0.26, 0.27) 0.25 (0.24, 0.25) 0.23 (0.22, 0.24)
Diagnostic confirmation
  Microscopic 15,975 0.51 (0.50, 0.51) 0.35 (0.34, 0.35) 0.30 (0.29, 0.30) 0.26 (0.26, 0.27) 0.24 (0.23, 0.25) 0.22 (0.21, 0.23)
  Other 4,895 0.36 (0.34, 0.37) 0.31 (0.30, 0.33) 0.29 (0.28, 0.30) 0.28 (0.26, 0.29) 0.26 (0.25, 0.27) 0.25 (0.23, 0.26)
Histology
  Glioblastoma multiforme 8,365 0.29 (0.28, 0.30) 0.10 (0.09, 0.11) 0.06 (0.05, 0.06) 0.04 (0.04, 0.05) 0.03 (0.03, 0.04) 0.03 (0.02, 0.03)
  Anaplastic astrocytoma 610 0.50 (0.46, 0.54) 0.34 (0.30, 0.38) 0.27 (0.23, 0.31) 0.22 (0.19, 0.26) 0.17 (0.14, 0.21) 0.14 (0.11, 0.18)
  Diffuse astrocytoma 2,310 0.45 (0.43, 0.47) 0.31 (0.29, 0.33) 0.26 (0.24, 0.27) 0.22 (0.20, 0.24) 0.19 (0.18, 0.21) 0.17 (0.15, 0.19)
  Anaplastic oligodendroglioma 555 0.74 (0.70, 0.78) 0.56 (0.52, 0.60) 0.48 (0.44, 0.53) 0.42 (0.38, 0.47) 0.36 (0.32, 0.41) 0.33 (0.28, 0.38)
  Oligoastrocytoma 720 0.76 (0.72, 0.79) 0.60 (0.57, 0.64) 0.54 (0.50, 0.58) 0.48 (0.44, 0.53) 0.41 (0.37, 0.46) 0.35 (0.31, 0.40)
  Oligodendroglioma 955 0.88 (0.86, 0.90) 0.82 (0.79, 0.84) 0.78 (0.75, 0.81) 0.73 (0.70, 0.76) 0.66 (0.63, 0.70) 0.60 (0.57, 0.65)
  Glioma (NOS) 1,050 0.52 (0.49, 0.55) 0.43 (0.40, 0.47) 0.40 (0.37, 0.43) 0.38 (0.35, 0.41) 0.35 (0.32, 0.38) 0.32 (0.29, 0.36)
  All others 6,305 0.60 (0.59, 0.61) 0.55 (0.54, 0.56) 0.51 (0.50, 0.52) 0.48 (0.47, 0.50) 0.46 (0.45, 0.47) 0.45 (0.43, 0.46)

CL = confidence limits.